Lucid Diagnostics Inc. · NASDAQ:LUCD

PAVmed Inc. reported a 27.50% stake in Lucid Diagnostics Inc. (Schedule 13D/A)

Event Feb 3, 2026 · Filed Feb 9, 2026

PAVmed Inc. reported a 27.50% stake in Lucid Diagnostics Inc., 38,816,903 shares, with active intent on Feb 3, 2026. Filed Feb 9, 2026 (Schedule 13D/A).

Stake
27.50%
Shares
38,816,903
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
PAVmed Inc.27.50%38,816,903

Source

View original at SEC

Related